WESTON HOUSE PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: L84033 | CHELTENHAM, GL50 4DP
Showing results 101-150 of 720
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Flucloxacillin sodium | 914 | 36.5K | £2.1K | +103.3% ▲ |
| Fluticasone propionate (Inhalation) | 905 | 1,110 | £20.0K | +133.9% ▲ |
| Warfarin sodium | 897 | 43.7K | £4.1K | +90.2% ▲ |
| Saxagliptin | 887 | 20.2K | £21.7K | +2,553.7% ▲ |
| Donepezil hydrochloride | 886 | 17.5K | £736 | +187.1% ▲ |
| Hydroxocobalamin | 875 | 913 | £2.0K | +81.8% ▲ |
| Desogestrel | 854 | 134.5K | £3.7K | +115.4% ▲ |
| Tolterodine | 851 | 20.7K | £1.1K | +472.4% ▲ |
| Esomeprazole | 845 | 28.0K | £1.7K | +108.8% ▲ |
| Pravastatin sodium | 798 | 24.3K | £1.1K | +145.7% ▲ |
| Quinine sulfate | 796 | 16.2K | £3.0K | +174.9% ▲ |
| Estradiol | 783 | 19.4K | £9.7K | +190.2% ▲ |
| 770 | 59.0K | £3.4K | +1,961.7% ▲ | |
| Methotrexate | 760 | 15.1K | £12.1K | +133.5% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 755 | 70.0K | £5.5K | +234.1% ▲ |
| Fluticasone/umeclidinium/vilanterol | 751 | 955 | £40.4K | +220.4% ▲ |
| Sumatriptan succinate | 737 | 6,397 | £4.1K | +108.1% ▲ |
| Felodipine | 690 | 20.2K | £2.0K | +16.2% ▲ |
| Baclofen | 690 | 45.2K | £1.2K | +244.4% ▲ |
| Aripiprazole | 689 | 10.9K | £1.4K | +170.8% ▲ |
| Cyanocobalamin | 685 | 37.7K | £3.0K | +94.0% ▲ |
| Mometasone furoate | 684 | 755 | £5.8K | +70.4% ▲ |
| Mebeverine hydrochloride | 683 | 43.2K | £1.7K | +120.0% ▲ |
| Umeclidinium bromide/vilanterol | 679 | 863 | £26.7K | +248.2% ▲ |
| Sacubitril/valsartan | 670 | 31.9K | £52.2K | +179.8% ▲ |
| Loperamide hydrochloride | 647 | 54.6K | £1.9K | +177.8% ▲ |
| 644 | 112.4K | £3.3K | +132.9% ▲ | |
| Insulin aspart | 623 | 4,136 | £24.5K | +63.6% ▲ |
| Bimatoprost | 621 | 6,447 | £4.8K | +317.8% ▲ |
| Lorazepam | 606 | 20.1K | £2.8K | +325.1% ▲ |
| Ferrous sulfate | 602 | 29.7K | £1.0K | +17.1% ▲ |
| Sitagliptin | 601 | 15.3K | £1.1K | +54.1% ▲ |
| Lisinopril | 591 | 18.5K | £440 | -46.1% ▼ |
| Clarithromycin | 586 | 16.9K | £3.0K | +138.8% ▲ |
| Topiramate | 578 | 25.9K | £5.6K | +225.2% ▲ |
| 568 | 667 | £29.7K | +82.9% ▲ | |
| Methylphenidate hydrochloride | 556 | 22.1K | £17.2K | +115.3% ▲ |
| Betamethasone valerate | 556 | 40.8K | £2.3K | +44.4% ▲ |
| Combined ethinylestradiol 30mcg | 545 | 66.6K | £4.5K | +96.2% ▲ |
| Oxycodone hydrochloride | 539 | 48.9K | £7.3K | +110.6% ▲ |
| Estriol | 538 | 10.8K | £4.2K | +152.8% ▲ |
| Fluticasone furoate | 534 | 588 | £4.1K | +175.7% ▲ |
| Clobetasone butyrate | 534 | 25.0K | £2.9K | +161.6% ▲ |
| 529 | 562 | £3.1K | +123.9% ▲ | |
| Co-beneldopa (Benserazide/levodopa) | 526 | 66.9K | £5.2K | +248.0% ▲ |
| Promethazine hydrochloride | 524 | 17.3K | £1.6K | +46.6% ▲ |
| Anastrozole | 522 | 15.7K | £612 | +473.3% ▲ |
| Estradiol with progestogen | 521 | 26.9K | £15.7K | +52.9% ▲ |
| Hydroxychloroquine sulfate | 521 | 23.3K | £1.1K | +169.0% ▲ |
| Eplerenone | 512 | 10.3K | £1.2K | +93.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.